Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast.

Kuerer, Henry M; Buzdar, Aman U; Mittendorf, Elizabeth A; Esteva, Francisco J; Lucci, Anthony; Vence, Luis M; Radvanyi, Laszlo; Meric-Bernstam, Funda; Hunt, Kelly K; Symmans, William Fraser

Kuerer, Henry M; Buzdar, Aman U; Mittendorf, Elizabeth A; Esteva, Francisco J; Lucci, Anthony; Vence, Luis M; Radvanyi, Laszlo; Meric-Bernstam, Funda; Hunt, Kelly K; Symmans, William Fraser.

Affiliation

Kuerer HM; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. hkuerer@mdanderson.org

Cancer ; 117(1): 39-47, 2011 Jan 01.

Article in En | MEDLINE | ID: mdl-20740500

Subject(s)

Antibodies, Monoclonal/administration & dosage; Antineoplastic Agents/administration & dosage; Breast Neoplasms/drug therapy; Carcinoma in Situ/drug therapy; Carcinoma, Ductal, Breast/drug therapy; Antibodies, Monoclonal/adverse effects; Antibodies, Monoclonal, Humanized; Antibody-Dependent Cell Cytotoxicity; Breast Neoplasms/immunology; Carcinoma in Situ/immunology; Carcinoma in Situ/surgery; Carcinoma, Ductal, Breast/immunology; Female; Humans; Middle Aged; Preoperative Period; Receptor, ErbB-2/metabolism; Trastuzumab; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma in Situ / Carcinoma, Ductal, Breast / Antibodies, Monoclonal / Antineoplastic Agents Limits: Female / Humans / Middle aged Language: En Journal: Cancer Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google